本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

32.95
+0.14000.43%
盤後32.950.00000.00%16:35 EDT
成交量:86.35萬
成交額:2,866.90萬
市值:19.60億
市盈率:-4.70
高:33.75
開:32.89
低:32.74
收:32.81
52周最高:46.00
52周最低:22.24
股本:5,947.16萬
流通股本:5,008.85萬
量比:0.93
換手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
淨資產收益率:-34.34%
總資產收益率:-22.24%
市淨率:1.91
市盈率(LYR):-4.63

資料載入中...

2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities